Intra-Cellular Therapies Inc (BSP:I2TC34)
R$ 71.15 0 (0%) Market Cap: 7.52 Bil Enterprise Value: 1.99 Bil PE Ratio: 0 PB Ratio: 6.94 GF Score: 38/100

Intra-Cellular Therapies Inc (BSP:I2TC34) Transcripts

  • 1